Pfizer will list its COVID-19 treatment Paxlovid at a price of $1,390 per five-day course when it soon hits the commercial market, the drugmaker confirmed to Axios.

Why it matters: Paxlovid’s new listed price, first reported by the Wall Street Journal, will be more than twice the $529 paid by the federal government, which until now has maintained the entire U.S. supply of the key antiviral medication.

  • KevonLooney@lemm.ee
    link
    fedilink
    arrow-up
    32
    arrow-down
    2
    ·
    1 year ago

    It does work, amazingly. I had Covid a few times and took Paxlovid the last time. It works better than any drug I’ve taken. After taking the first dose, there were no more Covid symptoms within 4-6 hours.

    The problem with Paxlovid (besides the cost) is that it gives you a new set of side effects: weird joint and muscle pain, a metallic taste in the mouth, etc. They’re better than Covid though. And it won’t kill you.

    • thepianistfroggollum@lemmynsfw.com
      link
      fedilink
      English
      arrow-up
      5
      arrow-down
      22
      ·
      1 year ago

      Just because it worked for you doesn’t mean that the effectiveness in their trials represents real world numbers. I’m not pulling this out of my ass, I was told this by a medical professional.

      • KevonLooney@lemm.ee
        link
        fedilink
        arrow-up
        18
        arrow-down
        2
        ·
        1 year ago

        There are many types of “medical professionals”. Only a vast minority actually read and interpret trial data.

        I’m going to trust my direct experience with the drug (I know it works) and real world studies like below.

        Conclusions: This study suggests that in the era of Omicron and in real-life settings, Paxlovid is highly effective in reducing the risk of severe COVID-19 or mortality.

        https://pubmed.ncbi.nlm.nih.gov/35653428/

        • SoleInvictus@lemmy.world
          link
          fedilink
          arrow-up
          10
          arrow-down
          4
          ·
          1 year ago

          Excuse me, that study only examined 140,219 patients. You’ll need WAY more, at least one million, to argue against the anecdotal opinion of a random, unspecified ‘medical professional’.

          /s so hard

          • thepianistfroggollum@lemmynsfw.com
            link
            fedilink
            English
            arrow-up
            2
            arrow-down
            5
            ·
            1 year ago

            Only 2.6% of the sample were given paxlovid, and they didn’t control for vaccination status.

            Also, it only covered 1 month nearly 2 years ago in a single country, and the virus has mutated several times since then.

            • Muddybulldog@mylemmy.win
              link
              fedilink
              English
              arrow-up
              2
              ·
              1 year ago

              Paxlovid is a 3CL protease inhibitor. It modifies the primary enzyme that is common across all cornavirus.

            • SoleInvictus@lemmy.world
              link
              fedilink
              arrow-up
              2
              ·
              1 year ago

              The best part about having a background in statistics is watching people who don’t understand statistics try to explain why the math that doesn’t support their point actually does, somehow.

        • FontMasterFlex@lemmy.world
          link
          fedilink
          arrow-up
          3
          arrow-down
          3
          ·
          1 year ago

          dude’s not saying it doesn’t work. he’s saying it doesn’t work as well as advertised. that perhaps doesn’t mean it’s only 50% effective for 100% people. perhaps it’s 100% effective for 20% of people. Think dude.

          • Jax@sh.itjust.works
            link
            fedilink
            arrow-up
            3
            arrow-down
            1
            ·
            edit-2
            1 year ago

            Yeah I’m gonna go ahead and say the guy throwing out accusations like false advertising is the one that needs to think a little more.

            Paxlovid has only ever been advertised as something that “can reduce the risk of hospitalization and death by around 89%”.

            The idea that, somehow, all of the people associated with coming to the “89%” number are somehow magically also associated with a subset of the population that responds well to it is fucking nonsense. It’s the exact same garbage logic that conspiracy theorists use.

        • thepianistfroggollum@lemmynsfw.com
          link
          fedilink
          English
          arrow-up
          2
          arrow-down
          3
          ·
          1 year ago

          Ah, that was the era of omicron. We’re over 21 months and several variants past that now, and I was given the information about paxlovid last week.

          Also, that study only covers a single month in Israel in 2022 and only 2.6% of the sample was given paxlovid.

      • superguy@lemm.ee
        link
        fedilink
        arrow-up
        1
        arrow-down
        1
        ·
        1 year ago

        I was told this by a medical professional.

        What about all the medical professionals that disagree with your medical professional?

        This is why people like you should keep quiet on matters they know nothing about. If you want to understand something, you have to research it yourself.